In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization.
Saved in:
| Title: | In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization. |
|---|---|
| Authors: | Zhang P; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Wu JC; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Wang H; Faculty of Materials Science, Shenzhen MSU-BIT University, Shenzhen, 518115, China. Electronic address: wanghr@smbu.edu.cn., You HH; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Wang DX; Department of PET-CT/MRI, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China., Jin JY; Department of PET-CT/MRI, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China., Duan HZ; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Li MS; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Li P; Department of PET-CT/MRI, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China., Wang K; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Tong ZC; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Guo PY; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Wang Z; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China. Electronic address: wangziqi@hrbmu.edu.cn., Zhao YB; Department of Urology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. Electronic address: zhaoyubo@hrbmu.edu.cn., Tang BZ; Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, Chinese University of Hong Kong (Shenzhen), Longgang, Shenzhen, Guangdong, 518172, China. Electronic address: tangbenz@cuhk.edu.cn., Hou DY; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China. Electronic address: houdayong@hrbmu.edu.cn. |
| Source: | Biomaterials [Biomaterials] 2026 Jun 27; Vol. 335, pp. 124405. Date of Electronic Publication: 2026 Jun 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8100316 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5905 (Electronic) Linking ISSN: 01429612 NLM ISO Abbreviation: Biomaterials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42372507 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+P%22">Zhang P</searchLink>; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Wu+JC%22">Wu JC</searchLink>; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Faculty of Materials Science, Shenzhen MSU-BIT University, Shenzhen, 518115, China. Electronic address: wanghr@smbu.edu.cn.<br /><searchLink fieldCode="AU" term="%22You+HH%22">You HH</searchLink>; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Wang+DX%22">Wang DX</searchLink>; Department of PET-CT/MRI, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Jin+JY%22">Jin JY</searchLink>; Department of PET-CT/MRI, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Duan+HZ%22">Duan HZ</searchLink>; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Li+MS%22">Li MS</searchLink>; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Li+P%22">Li P</searchLink>; Department of PET-CT/MRI, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Wang+K%22">Wang K</searchLink>; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Tong+ZC%22">Tong ZC</searchLink>; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Guo+PY%22">Guo PY</searchLink>; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China. Electronic address: wangziqi@hrbmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Zhao+YB%22">Zhao YB</searchLink>; Department of Urology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. Electronic address: zhaoyubo@hrbmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Tang+BZ%22">Tang BZ</searchLink>; Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, Chinese University of Hong Kong (Shenzhen), Longgang, Shenzhen, Guangdong, 518172, China. Electronic address: tangbenz@cuhk.edu.cn.<br /><searchLink fieldCode="AU" term="%22Hou+DY%22">Hou DY</searchLink>; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China. Electronic address: houdayong@hrbmu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228100316%22">Biomaterials</searchLink> [Biomaterials] 2026 Jun 27; Vol. 335, pp. 124405. <i>Date of Electronic Publication: </i>2026 Jun 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8100316 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-5905 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201429612%22">01429612 </searchLink><i>NLM ISO Abbreviation: </i>Biomaterials <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42372507 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.biomaterials.2026.124405 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 124405 Titles: – TitleFull: In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang P – PersonEntity: Name: NameFull: Wu JC – PersonEntity: Name: NameFull: Wang H – PersonEntity: Name: NameFull: You HH – PersonEntity: Name: NameFull: Wang DX – PersonEntity: Name: NameFull: Jin JY – PersonEntity: Name: NameFull: Duan HZ – PersonEntity: Name: NameFull: Li MS – PersonEntity: Name: NameFull: Li P – PersonEntity: Name: NameFull: Wang K – PersonEntity: Name: NameFull: Tong ZC – PersonEntity: Name: NameFull: Guo PY – PersonEntity: Name: NameFull: Wang Z – PersonEntity: Name: NameFull: Zhao YB – PersonEntity: Name: NameFull: Tang BZ – PersonEntity: Name: NameFull: Hou DY IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 06 Text: 2026 Jun 27 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1878-5905 Numbering: – Type: volume Value: 335 Titles: – TitleFull: Biomaterials Type: main |
| ResultId | 1 |